Recent advances in understanding the molecular mechanisms of tamoxifen action

Cancer Invest. 1998;16(6):391-6. doi: 10.3109/07357909809115779.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • 1-Phosphatidylinositol 4-Kinase / metabolism
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism
  • Antineoplastic Agents, Hormonal / pharmacology*
  • Antioxidants / pharmacology
  • Apoptosis / drug effects
  • Calmodulin / antagonists & inhibitors
  • Calmodulin / metabolism
  • Drug Resistance, Multiple
  • Enzyme Activation
  • Humans
  • Protein Kinase C / antagonists & inhibitors*
  • Protein Kinase C / metabolism
  • Tamoxifen / pharmacology*
  • Type C Phospholipases / antagonists & inhibitors
  • Type C Phospholipases / metabolism

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Antineoplastic Agents, Hormonal
  • Antioxidants
  • Calmodulin
  • Tamoxifen
  • 1-Phosphatidylinositol 4-Kinase
  • Protein Kinase C
  • Type C Phospholipases